Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals
Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals
复制标题
泛素连接酶 Cbl-b 通过激活线粒体途径并调节 Akt 和 ERK 生存信号使白血病和胃癌细胞对蒽环类药物敏感
DOI:
10.1016/j.febslet.2009.05.054
复制
发表时间:
2009-07-07
期刊:
影响因子:
3.5
通讯作者:
Liu, Yunpeng
中科院分区:
文献类型:
--
作者:
Qu, Xiujuan;Zhang, Ye;Liu, Yunpeng
The present study reported that the ubiquitin ligase Cbl-b was up-regulated during anthracycline-induced apoptosis in two cell lines, RBL-2H3 leukemia cells and MGC803 gastric cancer cells. Overexpression of Cbl-b strongly promoted the cytotoxic and apoptosis-inducing effects of anthracyclines, while a dominant negative (DN) Cbl-b mutation abolished these effects in both cell lines. Further investigation revealed that mitochondrial depolarization was enhanced by Cbl-b and decreased by Cbl-b (DN) in RBL-2H3 cells. Moreover, overexpression of Cbl-b significantly suppressed ERK activation, and Cbl-b (DN) strongly enhanced both ERK and Akt activation. Altogether, these results indicate that Cbl-b sensitized both leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial apoptotic pathway and modulating the ERK and Akt survival pathways. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.